Megan Webster

Megan Jo Webster, PhD, is a Principal Scientist and Head of Lung Platform at Newcells Biotech Ltd, where expertise in respiratory science drives strategic direction and project completion related to in-vitro lung models. Prior roles include Head of Lung Development, leading innovative research on lung disease models, and Scientist in Immunology and Respiratory Research at Boehringer Ingelheim, contributing to phase I clinical trial initiation. Previous experience includes post-doctoral research at the University of North Carolina at Chapel Hill, focusing on cystic fibrosis. Educational qualifications include a PhD in Cellular and Molecular Biology from Newcastle University and a Master of Research in Medical and Molecular Biosciences.